nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—skin cancer	0.887	1	CiPCiCtD
Nelarabine—DGUOK—nipple—skin cancer	0.00277	0.146	CbGeAlD
Nelarabine—DGUOK—mammalian vulva—skin cancer	0.00162	0.0854	CbGeAlD
Nelarabine—DGUOK—lymphoid tissue—skin cancer	0.00144	0.0758	CbGeAlD
Nelarabine—DGUOK—female reproductive system—skin cancer	0.00138	0.0731	CbGeAlD
Nelarabine—DGUOK—head—skin cancer	0.00116	0.0611	CbGeAlD
Nelarabine—ADA—connective tissue—skin cancer	0.00112	0.0593	CbGeAlD
Nelarabine—DCK—nipple—skin cancer	0.00105	0.0556	CbGeAlD
Nelarabine—POLA1—mammalian vulva—skin cancer	0.000997	0.0527	CbGeAlD
Nelarabine—ADA—mammalian vulva—skin cancer	0.000925	0.0488	CbGeAlD
Nelarabine—ADA—lymphoid tissue—skin cancer	0.000821	0.0434	CbGeAlD
Nelarabine—DGUOK—lymph node—skin cancer	0.00081	0.0428	CbGeAlD
Nelarabine—ADA—female reproductive system—skin cancer	0.000792	0.0418	CbGeAlD
Nelarabine—ADA—head—skin cancer	0.000662	0.0349	CbGeAlD
Nelarabine—DCK—mammalian vulva—skin cancer	0.000615	0.0325	CbGeAlD
Nelarabine—DCK—lymphoid tissue—skin cancer	0.000546	0.0288	CbGeAlD
Nelarabine—DCK—female reproductive system—skin cancer	0.000527	0.0278	CbGeAlD
Nelarabine—POLA1—lymph node—skin cancer	0.0005	0.0264	CbGeAlD
Nelarabine—ADA—lymph node—skin cancer	0.000463	0.0245	CbGeAlD
Nelarabine—DCK—head—skin cancer	0.00044	0.0232	CbGeAlD
Nelarabine—DCK—lymph node—skin cancer	0.000308	0.0163	CbGeAlD
Nelarabine—Stomatitis—Bleomycin—skin cancer	0.000194	0.00207	CcSEcCtD
Nelarabine—Loss of consciousness—Imiquimod—skin cancer	0.000192	0.00205	CcSEcCtD
Nelarabine—Muscular weakness—Temozolomide—skin cancer	0.000192	0.00205	CcSEcCtD
Nelarabine—Cough—Imiquimod—skin cancer	0.000191	0.00203	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000191	0.00203	CcSEcCtD
Nelarabine—Convulsion—Imiquimod—skin cancer	0.000189	0.00202	CcSEcCtD
Nelarabine—Abdominal distension—Temozolomide—skin cancer	0.000189	0.00202	CcSEcCtD
Nelarabine—Ataxia—Fluorouracil—skin cancer	0.000188	0.00201	CcSEcCtD
Nelarabine—Neuropathy—Docetaxel—skin cancer	0.000187	0.002	CcSEcCtD
Nelarabine—Pneumonia—Dactinomycin—skin cancer	0.000186	0.00199	CcSEcCtD
Nelarabine—Myalgia—Imiquimod—skin cancer	0.000186	0.00198	CcSEcCtD
Nelarabine—Arthralgia—Imiquimod—skin cancer	0.000186	0.00198	CcSEcCtD
Nelarabine—Chest pain—Imiquimod—skin cancer	0.000186	0.00198	CcSEcCtD
Nelarabine—Decreased appetite—Vemurafenib—skin cancer	0.000182	0.00194	CcSEcCtD
Nelarabine—Stomatitis—Dactinomycin—skin cancer	0.000181	0.00193	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000181	0.00193	CcSEcCtD
Nelarabine—Fatigue—Vemurafenib—skin cancer	0.00018	0.00192	CcSEcCtD
Nelarabine—Neoplasm—Docetaxel—skin cancer	0.00018	0.00192	CcSEcCtD
Nelarabine—Constipation—Vemurafenib—skin cancer	0.000179	0.00191	CcSEcCtD
Nelarabine—Oedema—Imiquimod—skin cancer	0.000178	0.0019	CcSEcCtD
Nelarabine—Hypoaesthesia—Bleomycin—skin cancer	0.000177	0.00189	CcSEcCtD
Nelarabine—Infection—Imiquimod—skin cancer	0.000177	0.00189	CcSEcCtD
Nelarabine—Muscular weakness—Fluorouracil—skin cancer	0.000177	0.00189	CcSEcCtD
Nelarabine—Neutropenia—Temozolomide—skin cancer	0.000176	0.00188	CcSEcCtD
Nelarabine—Nervous system disorder—Imiquimod—skin cancer	0.000175	0.00187	CcSEcCtD
Nelarabine—Sepsis—Docetaxel—skin cancer	0.000173	0.00184	CcSEcCtD
Nelarabine—Anorexia—Imiquimod—skin cancer	0.00017	0.00181	CcSEcCtD
Nelarabine—Hyperglycaemia—Temozolomide—skin cancer	0.00017	0.00181	CcSEcCtD
Nelarabine—Pneumonia—Temozolomide—skin cancer	0.000169	0.0018	CcSEcCtD
Nelarabine—Infestation NOS—Temozolomide—skin cancer	0.000168	0.00179	CcSEcCtD
Nelarabine—Infestation—Temozolomide—skin cancer	0.000168	0.00179	CcSEcCtD
Nelarabine—Depression—Temozolomide—skin cancer	0.000167	0.00178	CcSEcCtD
Nelarabine—Body temperature increased—Vemurafenib—skin cancer	0.000165	0.00176	CcSEcCtD
Nelarabine—Neuropathy peripheral—Temozolomide—skin cancer	0.000164	0.00175	CcSEcCtD
Nelarabine—Stomatitis—Temozolomide—skin cancer	0.000163	0.00174	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000162	0.00173	CcSEcCtD
Nelarabine—Insomnia—Imiquimod—skin cancer	0.000161	0.00172	CcSEcCtD
Nelarabine—Paraesthesia—Imiquimod—skin cancer	0.00016	0.00171	CcSEcCtD
Nelarabine—Chills—Bleomycin—skin cancer	0.00016	0.00171	CcSEcCtD
Nelarabine—Dyspnoea—Imiquimod—skin cancer	0.000159	0.0017	CcSEcCtD
Nelarabine—Somnolence—Imiquimod—skin cancer	0.000159	0.00169	CcSEcCtD
Nelarabine—Hepatobiliary disease—Temozolomide—skin cancer	0.000158	0.00169	CcSEcCtD
Nelarabine—Sinusitis—Temozolomide—skin cancer	0.000157	0.00168	CcSEcCtD
Nelarabine—Pneumonia—Fluorouracil—skin cancer	0.000155	0.00166	CcSEcCtD
Nelarabine—Decreased appetite—Imiquimod—skin cancer	0.000155	0.00165	CcSEcCtD
Nelarabine—Infestation NOS—Fluorouracil—skin cancer	0.000154	0.00165	CcSEcCtD
Nelarabine—Infestation—Fluorouracil—skin cancer	0.000154	0.00165	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000154	0.00164	CcSEcCtD
Nelarabine—Fatigue—Imiquimod—skin cancer	0.000154	0.00164	CcSEcCtD
Nelarabine—Pain—Imiquimod—skin cancer	0.000153	0.00163	CcSEcCtD
Nelarabine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000151	0.00161	CcSEcCtD
Nelarabine—Stomatitis—Fluorouracil—skin cancer	0.00015	0.00161	CcSEcCtD
Nelarabine—Asthenia—Vemurafenib—skin cancer	0.00015	0.0016	CcSEcCtD
Nelarabine—Hypoaesthesia—Temozolomide—skin cancer	0.00015	0.0016	CcSEcCtD
Nelarabine—Chills—Dactinomycin—skin cancer	0.000149	0.00159	CcSEcCtD
Nelarabine—Urinary tract disorder—Temozolomide—skin cancer	0.000149	0.00159	CcSEcCtD
Nelarabine—Oedema peripheral—Temozolomide—skin cancer	0.000148	0.00158	CcSEcCtD
Nelarabine—Connective tissue disorder—Temozolomide—skin cancer	0.000148	0.00158	CcSEcCtD
Nelarabine—Lethargy—Docetaxel—skin cancer	0.000148	0.00157	CcSEcCtD
Nelarabine—Urethral disorder—Temozolomide—skin cancer	0.000147	0.00157	CcSEcCtD
Nelarabine—Feeling abnormal—Imiquimod—skin cancer	0.000147	0.00157	CcSEcCtD
Nelarabine—Gastrointestinal pain—Imiquimod—skin cancer	0.000146	0.00156	CcSEcCtD
Nelarabine—Epistaxis—Fluorouracil—skin cancer	0.000146	0.00155	CcSEcCtD
Nelarabine—Sinusitis—Fluorouracil—skin cancer	0.000145	0.00155	CcSEcCtD
Nelarabine—Pain in extremity—Docetaxel—skin cancer	0.000145	0.00154	CcSEcCtD
Nelarabine—Anaemia—Bleomycin—skin cancer	0.000143	0.00153	CcSEcCtD
Nelarabine—Diarrhoea—Vemurafenib—skin cancer	0.000143	0.00153	CcSEcCtD
Nelarabine—Abdominal pain—Imiquimod—skin cancer	0.000141	0.0015	CcSEcCtD
Nelarabine—Body temperature increased—Imiquimod—skin cancer	0.000141	0.0015	CcSEcCtD
Nelarabine—Eye disorder—Temozolomide—skin cancer	0.000141	0.0015	CcSEcCtD
Nelarabine—Cardiac disorder—Temozolomide—skin cancer	0.00014	0.00149	CcSEcCtD
Nelarabine—Leukopenia—Bleomycin—skin cancer	0.000139	0.00148	CcSEcCtD
Nelarabine—Dizziness—Vemurafenib—skin cancer	0.000138	0.00148	CcSEcCtD
Nelarabine—Hypoaesthesia—Fluorouracil—skin cancer	0.000138	0.00147	CcSEcCtD
Nelarabine—Angiopathy—Temozolomide—skin cancer	0.000136	0.00146	CcSEcCtD
Nelarabine—Ataxia—Docetaxel—skin cancer	0.000136	0.00145	CcSEcCtD
Nelarabine—Mediastinal disorder—Temozolomide—skin cancer	0.000136	0.00145	CcSEcCtD
Nelarabine—Cough—Bleomycin—skin cancer	0.000135	0.00145	CcSEcCtD
Nelarabine—Chills—Temozolomide—skin cancer	0.000135	0.00144	CcSEcCtD
Nelarabine—Dehydration—Docetaxel—skin cancer	0.000134	0.00143	CcSEcCtD
Nelarabine—Anaemia—Dactinomycin—skin cancer	0.000134	0.00143	CcSEcCtD
Nelarabine—Vomiting—Vemurafenib—skin cancer	0.000133	0.00142	CcSEcCtD
Nelarabine—Chest pain—Bleomycin—skin cancer	0.000132	0.00141	CcSEcCtD
Nelarabine—Myalgia—Bleomycin—skin cancer	0.000132	0.00141	CcSEcCtD
Nelarabine—Mental disorder—Temozolomide—skin cancer	0.000132	0.00141	CcSEcCtD
Nelarabine—Headache—Vemurafenib—skin cancer	0.000131	0.0014	CcSEcCtD
Nelarabine—Malnutrition—Temozolomide—skin cancer	0.000131	0.0014	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00013	0.00139	CcSEcCtD
Nelarabine—Leukopenia—Dactinomycin—skin cancer	0.00013	0.00138	CcSEcCtD
Nelarabine—Dysgeusia—Temozolomide—skin cancer	0.000128	0.00137	CcSEcCtD
Nelarabine—Asthenia—Imiquimod—skin cancer	0.000128	0.00137	CcSEcCtD
Nelarabine—Confusional state—Bleomycin—skin cancer	0.000128	0.00136	CcSEcCtD
Nelarabine—Oedema—Bleomycin—skin cancer	0.000127	0.00135	CcSEcCtD
Nelarabine—Back pain—Temozolomide—skin cancer	0.000127	0.00135	CcSEcCtD
Nelarabine—Infection—Bleomycin—skin cancer	0.000126	0.00134	CcSEcCtD
Nelarabine—Nausea—Vemurafenib—skin cancer	0.000124	0.00133	CcSEcCtD
Nelarabine—Thrombocytopenia—Bleomycin—skin cancer	0.000124	0.00132	CcSEcCtD
Nelarabine—Vision blurred—Temozolomide—skin cancer	0.000123	0.00132	CcSEcCtD
Nelarabine—Myalgia—Dactinomycin—skin cancer	0.000123	0.00132	CcSEcCtD
Nelarabine—Tremor—Temozolomide—skin cancer	0.000123	0.00131	CcSEcCtD
Nelarabine—Diarrhoea—Imiquimod—skin cancer	0.000122	0.0013	CcSEcCtD
Nelarabine—Anaemia—Temozolomide—skin cancer	0.000121	0.00129	CcSEcCtD
Nelarabine—Anorexia—Bleomycin—skin cancer	0.000121	0.00129	CcSEcCtD
Nelarabine—Hypotension—Bleomycin—skin cancer	0.000118	0.00126	CcSEcCtD
Nelarabine—Oedema—Dactinomycin—skin cancer	0.000118	0.00126	CcSEcCtD
Nelarabine—Dizziness—Imiquimod—skin cancer	0.000118	0.00126	CcSEcCtD
Nelarabine—Infection—Dactinomycin—skin cancer	0.000117	0.00125	CcSEcCtD
Nelarabine—Leukopenia—Temozolomide—skin cancer	0.000117	0.00125	CcSEcCtD
Nelarabine—Neutropenia—Docetaxel—skin cancer	0.000117	0.00125	CcSEcCtD
Nelarabine—Thrombocytopenia—Dactinomycin—skin cancer	0.000116	0.00123	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000115	0.00123	CcSEcCtD
Nelarabine—Cough—Temozolomide—skin cancer	0.000114	0.00122	CcSEcCtD
Nelarabine—Paraesthesia—Bleomycin—skin cancer	0.000114	0.00121	CcSEcCtD
Nelarabine—Vision blurred—Fluorouracil—skin cancer	0.000114	0.00121	CcSEcCtD
Nelarabine—Convulsion—Temozolomide—skin cancer	0.000113	0.00121	CcSEcCtD
Nelarabine—Vomiting—Imiquimod—skin cancer	0.000113	0.00121	CcSEcCtD
Nelarabine—Dyspnoea—Bleomycin—skin cancer	0.000113	0.00121	CcSEcCtD
Nelarabine—Anorexia—Dactinomycin—skin cancer	0.000113	0.0012	CcSEcCtD
Nelarabine—Pneumonia—Docetaxel—skin cancer	0.000112	0.0012	CcSEcCtD
Nelarabine—Headache—Imiquimod—skin cancer	0.000112	0.00119	CcSEcCtD
Nelarabine—Anaemia—Fluorouracil—skin cancer	0.000112	0.00119	CcSEcCtD
Nelarabine—Arthralgia—Temozolomide—skin cancer	0.000111	0.00119	CcSEcCtD
Nelarabine—Myalgia—Temozolomide—skin cancer	0.000111	0.00119	CcSEcCtD
Nelarabine—Infestation NOS—Docetaxel—skin cancer	0.000111	0.00119	CcSEcCtD
Nelarabine—Infestation—Docetaxel—skin cancer	0.000111	0.00119	CcSEcCtD
Nelarabine—Decreased appetite—Bleomycin—skin cancer	0.00011	0.00118	CcSEcCtD
Nelarabine—Neuropathy peripheral—Docetaxel—skin cancer	0.000109	0.00117	CcSEcCtD
Nelarabine—Stomatitis—Docetaxel—skin cancer	0.000109	0.00116	CcSEcCtD
Nelarabine—Pain—Bleomycin—skin cancer	0.000108	0.00116	CcSEcCtD
Nelarabine—Leukopenia—Fluorouracil—skin cancer	0.000108	0.00115	CcSEcCtD
Nelarabine—Confusional state—Temozolomide—skin cancer	0.000108	0.00115	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000108	0.00115	CcSEcCtD
Nelarabine—Oedema—Temozolomide—skin cancer	0.000107	0.00114	CcSEcCtD
Nelarabine—Infection—Temozolomide—skin cancer	0.000106	0.00113	CcSEcCtD
Nelarabine—Nausea—Imiquimod—skin cancer	0.000106	0.00113	CcSEcCtD
Nelarabine—Hepatobiliary disease—Docetaxel—skin cancer	0.000105	0.00112	CcSEcCtD
Nelarabine—Epistaxis—Docetaxel—skin cancer	0.000105	0.00112	CcSEcCtD
Nelarabine—Nervous system disorder—Temozolomide—skin cancer	0.000105	0.00112	CcSEcCtD
Nelarabine—Thrombocytopenia—Temozolomide—skin cancer	0.000105	0.00112	CcSEcCtD
Nelarabine—Convulsion—Fluorouracil—skin cancer	0.000105	0.00112	CcSEcCtD
Nelarabine—Feeling abnormal—Bleomycin—skin cancer	0.000104	0.00111	CcSEcCtD
Nelarabine—Chest pain—Fluorouracil—skin cancer	0.000103	0.0011	CcSEcCtD
Nelarabine—Myalgia—Fluorouracil—skin cancer	0.000103	0.0011	CcSEcCtD
Nelarabine—Decreased appetite—Dactinomycin—skin cancer	0.000103	0.0011	CcSEcCtD
Nelarabine—Fatigue—Dactinomycin—skin cancer	0.000102	0.00109	CcSEcCtD
Nelarabine—Anorexia—Temozolomide—skin cancer	0.000102	0.00109	CcSEcCtD
Nelarabine—Pain—Dactinomycin—skin cancer	0.000101	0.00108	CcSEcCtD
Nelarabine—Body temperature increased—Bleomycin—skin cancer	0.0001	0.00107	CcSEcCtD
Nelarabine—Hypoaesthesia—Docetaxel—skin cancer	9.95e-05	0.00106	CcSEcCtD
Nelarabine—Confusional state—Fluorouracil—skin cancer	9.93e-05	0.00106	CcSEcCtD
Nelarabine—Urinary tract disorder—Docetaxel—skin cancer	9.88e-05	0.00105	CcSEcCtD
Nelarabine—Oedema peripheral—Docetaxel—skin cancer	9.85e-05	0.00105	CcSEcCtD
Nelarabine—Oedema—Fluorouracil—skin cancer	9.85e-05	0.00105	CcSEcCtD
Nelarabine—Connective tissue disorder—Docetaxel—skin cancer	9.83e-05	0.00105	CcSEcCtD
Nelarabine—Urethral disorder—Docetaxel—skin cancer	9.81e-05	0.00105	CcSEcCtD
Nelarabine—Infection—Fluorouracil—skin cancer	9.78e-05	0.00104	CcSEcCtD
Nelarabine—Feeling abnormal—Dactinomycin—skin cancer	9.74e-05	0.00104	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Temozolomide—skin cancer	9.74e-05	0.00104	CcSEcCtD
Nelarabine—Insomnia—Temozolomide—skin cancer	9.67e-05	0.00103	CcSEcCtD
Nelarabine—Gastrointestinal pain—Dactinomycin—skin cancer	9.66e-05	0.00103	CcSEcCtD
Nelarabine—Nervous system disorder—Fluorouracil—skin cancer	9.66e-05	0.00103	CcSEcCtD
Nelarabine—Thrombocytopenia—Fluorouracil—skin cancer	9.64e-05	0.00103	CcSEcCtD
Nelarabine—Paraesthesia—Temozolomide—skin cancer	9.6e-05	0.00102	CcSEcCtD
Nelarabine—Dyspnoea—Temozolomide—skin cancer	9.53e-05	0.00102	CcSEcCtD
Nelarabine—Somnolence—Temozolomide—skin cancer	9.5e-05	0.00101	CcSEcCtD
Nelarabine—Anorexia—Fluorouracil—skin cancer	9.39e-05	0.001	CcSEcCtD
Nelarabine—Eye disorder—Docetaxel—skin cancer	9.35e-05	0.000997	CcSEcCtD
Nelarabine—Abdominal pain—Dactinomycin—skin cancer	9.34e-05	0.000997	CcSEcCtD
Nelarabine—Body temperature increased—Dactinomycin—skin cancer	9.34e-05	0.000997	CcSEcCtD
Nelarabine—Decreased appetite—Temozolomide—skin cancer	9.29e-05	0.000991	CcSEcCtD
Nelarabine—Cardiac disorder—Docetaxel—skin cancer	9.28e-05	0.000991	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Temozolomide—skin cancer	9.23e-05	0.000984	CcSEcCtD
Nelarabine—Fatigue—Temozolomide—skin cancer	9.21e-05	0.000983	CcSEcCtD
Nelarabine—Hypotension—Fluorouracil—skin cancer	9.2e-05	0.000982	CcSEcCtD
Nelarabine—Pain—Temozolomide—skin cancer	9.14e-05	0.000975	CcSEcCtD
Nelarabine—Constipation—Temozolomide—skin cancer	9.14e-05	0.000975	CcSEcCtD
Nelarabine—Asthenia—Bleomycin—skin cancer	9.09e-05	0.00097	CcSEcCtD
Nelarabine—Angiopathy—Docetaxel—skin cancer	9.08e-05	0.000968	CcSEcCtD
Nelarabine—Mediastinal disorder—Docetaxel—skin cancer	9.02e-05	0.000962	CcSEcCtD
Nelarabine—Chills—Docetaxel—skin cancer	8.98e-05	0.000958	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Fluorouracil—skin cancer	8.97e-05	0.000957	CcSEcCtD
Nelarabine—Insomnia—Fluorouracil—skin cancer	8.91e-05	0.00095	CcSEcCtD
Nelarabine—Paraesthesia—Fluorouracil—skin cancer	8.84e-05	0.000943	CcSEcCtD
Nelarabine—Feeling abnormal—Temozolomide—skin cancer	8.81e-05	0.00094	CcSEcCtD
Nelarabine—Dyspnoea—Fluorouracil—skin cancer	8.78e-05	0.000937	CcSEcCtD
Nelarabine—Mental disorder—Docetaxel—skin cancer	8.76e-05	0.000935	CcSEcCtD
Nelarabine—Somnolence—Fluorouracil—skin cancer	8.75e-05	0.000934	CcSEcCtD
Nelarabine—Gastrointestinal pain—Temozolomide—skin cancer	8.74e-05	0.000932	CcSEcCtD
Nelarabine—Malnutrition—Docetaxel—skin cancer	8.71e-05	0.000929	CcSEcCtD
Nelarabine—Decreased appetite—Fluorouracil—skin cancer	8.56e-05	0.000913	CcSEcCtD
Nelarabine—Dysgeusia—Docetaxel—skin cancer	8.53e-05	0.00091	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Fluorouracil—skin cancer	8.5e-05	0.000907	CcSEcCtD
Nelarabine—Asthenia—Dactinomycin—skin cancer	8.48e-05	0.000905	CcSEcCtD
Nelarabine—Abdominal pain—Temozolomide—skin cancer	8.45e-05	0.000901	CcSEcCtD
Nelarabine—Body temperature increased—Temozolomide—skin cancer	8.45e-05	0.000901	CcSEcCtD
Nelarabine—Back pain—Docetaxel—skin cancer	8.42e-05	0.000899	CcSEcCtD
Nelarabine—Pain—Fluorouracil—skin cancer	8.42e-05	0.000898	CcSEcCtD
Nelarabine—Feeling abnormal—Fluorouracil—skin cancer	8.11e-05	0.000866	CcSEcCtD
Nelarabine—Diarrhoea—Dactinomycin—skin cancer	8.08e-05	0.000863	CcSEcCtD
Nelarabine—Vomiting—Bleomycin—skin cancer	8.06e-05	0.000859	CcSEcCtD
Nelarabine—Anaemia—Docetaxel—skin cancer	8.05e-05	0.000859	CcSEcCtD
Nelarabine—Leukopenia—Docetaxel—skin cancer	7.79e-05	0.000832	CcSEcCtD
Nelarabine—Body temperature increased—Fluorouracil—skin cancer	7.78e-05	0.000831	CcSEcCtD
Nelarabine—Asthenia—Temozolomide—skin cancer	7.67e-05	0.000818	CcSEcCtD
Nelarabine—Loss of consciousness—Docetaxel—skin cancer	7.65e-05	0.000817	CcSEcCtD
Nelarabine—Cough—Docetaxel—skin cancer	7.6e-05	0.000811	CcSEcCtD
Nelarabine—Convulsion—Docetaxel—skin cancer	7.54e-05	0.000805	CcSEcCtD
Nelarabine—Nausea—Bleomycin—skin cancer	7.53e-05	0.000803	CcSEcCtD
Nelarabine—Vomiting—Dactinomycin—skin cancer	7.51e-05	0.000802	CcSEcCtD
Nelarabine—Chest pain—Docetaxel—skin cancer	7.41e-05	0.000791	CcSEcCtD
Nelarabine—Arthralgia—Docetaxel—skin cancer	7.41e-05	0.000791	CcSEcCtD
Nelarabine—Myalgia—Docetaxel—skin cancer	7.41e-05	0.000791	CcSEcCtD
Nelarabine—Diarrhoea—Temozolomide—skin cancer	7.31e-05	0.00078	CcSEcCtD
Nelarabine—Confusional state—Docetaxel—skin cancer	7.17e-05	0.000765	CcSEcCtD
Nelarabine—Oedema—Docetaxel—skin cancer	7.11e-05	0.000758	CcSEcCtD
Nelarabine—Dizziness—Temozolomide—skin cancer	7.07e-05	0.000754	CcSEcCtD
Nelarabine—Infection—Docetaxel—skin cancer	7.06e-05	0.000753	CcSEcCtD
Nelarabine—Nausea—Dactinomycin—skin cancer	7.02e-05	0.000749	CcSEcCtD
Nelarabine—Nervous system disorder—Docetaxel—skin cancer	6.97e-05	0.000744	CcSEcCtD
Nelarabine—Thrombocytopenia—Docetaxel—skin cancer	6.96e-05	0.000742	CcSEcCtD
Nelarabine—Vomiting—Temozolomide—skin cancer	6.79e-05	0.000725	CcSEcCtD
Nelarabine—Anorexia—Docetaxel—skin cancer	6.77e-05	0.000723	CcSEcCtD
Nelarabine—Diarrhoea—Fluorouracil—skin cancer	6.74e-05	0.000719	CcSEcCtD
Nelarabine—Headache—Temozolomide—skin cancer	6.7e-05	0.000714	CcSEcCtD
Nelarabine—Hypotension—Docetaxel—skin cancer	6.64e-05	0.000709	CcSEcCtD
Nelarabine—Dizziness—Fluorouracil—skin cancer	6.51e-05	0.000695	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Docetaxel—skin cancer	6.48e-05	0.000691	CcSEcCtD
Nelarabine—Insomnia—Docetaxel—skin cancer	6.43e-05	0.000686	CcSEcCtD
Nelarabine—Paraesthesia—Docetaxel—skin cancer	6.38e-05	0.000681	CcSEcCtD
Nelarabine—Nausea—Temozolomide—skin cancer	6.35e-05	0.000677	CcSEcCtD
Nelarabine—Dyspnoea—Docetaxel—skin cancer	6.34e-05	0.000676	CcSEcCtD
Nelarabine—Somnolence—Docetaxel—skin cancer	6.32e-05	0.000674	CcSEcCtD
Nelarabine—Vomiting—Fluorouracil—skin cancer	6.26e-05	0.000668	CcSEcCtD
Nelarabine—Decreased appetite—Docetaxel—skin cancer	6.18e-05	0.000659	CcSEcCtD
Nelarabine—Headache—Fluorouracil—skin cancer	6.17e-05	0.000658	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Docetaxel—skin cancer	6.14e-05	0.000655	CcSEcCtD
Nelarabine—Fatigue—Docetaxel—skin cancer	6.13e-05	0.000654	CcSEcCtD
Nelarabine—Constipation—Docetaxel—skin cancer	6.08e-05	0.000648	CcSEcCtD
Nelarabine—Pain—Docetaxel—skin cancer	6.08e-05	0.000648	CcSEcCtD
Nelarabine—Feeling abnormal—Docetaxel—skin cancer	5.86e-05	0.000625	CcSEcCtD
Nelarabine—Nausea—Fluorouracil—skin cancer	5.85e-05	0.000624	CcSEcCtD
Nelarabine—Gastrointestinal pain—Docetaxel—skin cancer	5.81e-05	0.00062	CcSEcCtD
Nelarabine—Body temperature increased—Docetaxel—skin cancer	5.62e-05	0.000599	CcSEcCtD
Nelarabine—Abdominal pain—Docetaxel—skin cancer	5.62e-05	0.000599	CcSEcCtD
Nelarabine—Asthenia—Docetaxel—skin cancer	5.1e-05	0.000544	CcSEcCtD
Nelarabine—Diarrhoea—Docetaxel—skin cancer	4.86e-05	0.000519	CcSEcCtD
Nelarabine—Dizziness—Docetaxel—skin cancer	4.7e-05	0.000501	CcSEcCtD
Nelarabine—Vomiting—Docetaxel—skin cancer	4.52e-05	0.000482	CcSEcCtD
Nelarabine—Headache—Docetaxel—skin cancer	4.45e-05	0.000475	CcSEcCtD
Nelarabine—Nausea—Docetaxel—skin cancer	4.22e-05	0.00045	CcSEcCtD
